These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3363012)
1. Concentration and distribution of thioridazine and metabolites in schizophrenic post-mortem brain tissue. Svendsen CN; Hrbek CC; Casendino M; Nichols RD; Bird ED Psychiatry Res; 1988 Jan; 23(1):1-10. PubMed ID: 3363012 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients. Carrillo JA; Ramos SI; Herraiz AG; Llerena A; Agundez JA; Berecz R; Duran M; Benítez J J Clin Psychopharmacol; 1999 Dec; 19(6):494-9. PubMed ID: 10587283 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment. Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048 [TBL] [Abstract][Full Text] [Related]
4. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine. Eap CB; Souche A; Koeb L; Baumann P Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970 [TBL] [Abstract][Full Text] [Related]
6. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum. Niedzwiecki DM; Cubeddu LX; Mailman RB J Pharmacol Exp Ther; 1989 Jul; 250(1):117-25. PubMed ID: 2746491 [TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia. Widerlöv E; Häggström JE; Kilts CD; Andersson U; Breese GR; Mailman RB Acta Psychiatr Scand; 1982 Oct; 66(4):294-305. PubMed ID: 7148482 [TBL] [Abstract][Full Text] [Related]
8. Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Tsuneizumi T; Babb SM; Cohen BM Biol Psychiatry; 1992 Nov; 32(9):817-24. PubMed ID: 1360262 [TBL] [Abstract][Full Text] [Related]
9. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study. Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782 [TBL] [Abstract][Full Text] [Related]
10. Important metabolites to measure in pharmacodynamic studies of chlorpromazine. Chetty M; Moodley SV; Miller R Ther Drug Monit; 1994 Feb; 16(1):30-6. PubMed ID: 8160251 [TBL] [Abstract][Full Text] [Related]
11. Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma. Eap CB; Koeb L; Powell K; Baumann P J Chromatogr B Biomed Appl; 1995 Jul; 669(2):271-9. PubMed ID: 7581903 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine. Daniel WA; Syrek M; Haduch A; Wójcikowski J Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926 [TBL] [Abstract][Full Text] [Related]
13. Absorption and excretion of thioridazine and mesoridazine in man. Charalampous KD; Johnson PC; Estevez V Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456 [TBL] [Abstract][Full Text] [Related]
14. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors. Niedzwiecki DM; Mailman RB; Cubeddu LX J Pharmacol Exp Ther; 1984 Mar; 228(3):636-9. PubMed ID: 6707914 [TBL] [Abstract][Full Text] [Related]
15. S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers. Chakraborty BS; Hawes EM; McKay G; Hubbard JW; Korchinski ED; Midha KK; Choc MG; Robinson WT Drug Metabol Drug Interact; 1988; 6(3-4):425-37. PubMed ID: 3271648 [TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics and density functional studies on the metabolic selectivity of antipsychotic thioridazine by cytochrome P450 2D6: Connection with crystallographic and metabolic results. Sasahara K; Mashima A; Yoshida T; Chuman H Bioorg Med Chem; 2015 Sep; 23(17):5459-65. PubMed ID: 26264841 [TBL] [Abstract][Full Text] [Related]
17. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites. Cohen BM; Lipinski JF; Waternaux C Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945 [TBL] [Abstract][Full Text] [Related]
18. Identification of lactams as in vitro metabolites of piperidine-type phenothiazine antipsychotic drugs. Lin G; Chu KW; Damani LA; Hawes EM; Midha KK J Pharm Biomed Anal; 1996 Apr; 14(6):727-38. PubMed ID: 8807548 [TBL] [Abstract][Full Text] [Related]
19. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics. Young AS; Faraone SV; Brown WA J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620 [TBL] [Abstract][Full Text] [Related]
20. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients. Shvartsburd A; Nwokeafor V; Smith RC Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]